Vyome Holdings (HIND) Accounts Payables (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Accounts Payables of $532131.0 for Q1 2026, down 68.44% year-over-year from $1.7 million in Q1 2025, and down 58.64% quarter-over-quarter from $1.3 million in Q4 2025.
Vyome Holdings (HIND) Accounts Payables (2015 - 2026) Analysis & Trends
Vyome Holdings' Accounts Payables history runs 12 years deep, the most recent figure standing at $532131.0 for Q1 2026.
- In Q1 2026, Accounts Payables fell 68.44% year-over-year to $532131.0; the TTM figure through Mar 2026 stood at $532131.0 (down 68.44% YoY), while the FY2025 annual figure was $1.3 million, up 33.25% from the prior year.
- Accounts Payables for Q1 2026 stood at $532131.0, down from $1.3 million in the prior quarter.
- The five-year high for Accounts Payables was $3.6 million in Q1 2022, with the low at $532131.0 in Q1 2026.
- The 5-year median for Accounts Payables is $1.7 million (2025), against an average of $1.7 million.
- The sharpest annual moves came in 2022 and 2026: Accounts Payables soared 518.21% in 2022, then tumbled 68.44% in 2026.
- Vyome Holdings' Accounts Payables stood at $1.9 million in 2022, then retreated by 12.31% to $1.7 million in 2023, then plunged by 42.83% to $965607.0 in 2024, then soared by 33.25% to $1.3 million in 2025, then sank by 58.64% to $532131.0 in 2026.
- Business Quant data shows HIND's Accounts Payables at $532131.0 in Q1 2026, $1.3 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Mar 31, 2026 | 532,131.00 |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 965,607.00 |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 2.51 Mn |
| Mar 31, 2022 | 3.60 Mn |
| Dec 31, 2021 | 3.47 Mn |
| Sep 30, 2021 | 3.11 Mn |